refs[] |
{'index': 0, 'target_release_id': None, 'extra': {'authors': ['Bray'], 'doi': '10.3322/caac.21660', 'volume': '7'}, 'key': '1', 'year': 2021, 'container_name': 'CA Cancer J Clin', 'title': 'Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries', 'locator': '209'}
{'index': 1, 'target_release_id': None, 'extra': {'authors': ['Persson'], 'doi': '10.2174/138945012802429615', 'volume': '1'}, 'key': '2', 'year': 2012, 'container_name': 'Curr Drug Targets', 'title': 'Overcoming drug resistance and treating advanced prostate cancer', 'locator': '1308'}
{'index': 2, 'target_release_id': None, 'extra': {'authors': ['Studer'], 'doi': '10.1016/j.eururo.2008.10.008', 'volume': '5'}, 'key': '3', 'year': 2009, 'container_name': 'Eur Urol', 'title': 'Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks', 'locator': '62'}
{'index': 3, 'target_release_id': None, 'extra': {'authors': ['Fléchon'], 'doi': '10.1056/nejmoa1207506', 'volume': '36'}, 'key': '4', 'year': 2012, 'container_name': 'N Engl J Med', 'title': 'Increased survival with enzalutamide in prostate cancer after chemotherapy', 'locator': '1187'}
{'index': 4, 'target_release_id': None, 'extra': {'authors': ['Harland'], 'doi': '10.1056/nejmoa1014618', 'volume': '36'}, 'key': '5', 'year': 2011, 'container_name': 'N Engl J Med', 'title': 'Abiraterone and increased survival in metastatic prostate cancer', 'locator': '1995'}
{'index': 5, 'target_release_id': None, 'extra': {'authors': ['Tindall'], 'doi': '10.1093/jnci/93.22.1687', 'volume': '9'}, 'key': '6', 'year': 2001, 'container_name': 'J Natl Cancer Inst', 'title': 'Androgen receptor signaling in androgen-refractory prostate cancer', 'locator': '1687'}
{'index': 6, 'target_release_id': None, 'extra': {'authors': ['Chang'], 'doi': '10.1210/er.2002-0032', 'volume': '2'}, 'key': '7', 'year': 2004, 'container_name': 'Endocr Rev', 'title': 'Androgen receptor in prostate cancer', 'locator': '276'}
{'index': 7, 'target_release_id': None, 'extra': {'authors': ['Farrar'], 'doi': '10.1097/00045391-200603000-00013', 'volume': '1'}, 'key': '8', 'year': 2006, 'container_name': 'Am J Ther', 'title': 'Androgen receptor as a therapeutic target for androgen independent prostate cancer', 'locator': '166'}
{'index': 8, 'target_release_id': None, 'extra': {'authors': ['Schram'], 'doi': '10.1038/nm.4333', 'volume': '2'}, 'key': '9', 'year': 2017, 'container_name': 'Nat Med', 'title': 'Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients', 'locator': '703'}
{'index': 9, 'target_release_id': None, 'extra': {'authors': ['Clarke'], 'doi': '10.1186/s13073-016-0364-2', 'volume': '8'}, 'key': '10', 'year': 2016, 'container_name': 'Genome Med', 'title': 'Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial', 'locator': '109'}
{'index': 10, 'target_release_id': None, 'extra': {'authors': ['Konopleva'], 'doi': '10.1182/blood.2019001034', 'volume': '13'}, 'key': '11', 'year': 2019, 'container_name': 'Blood', 'title': 'Amino acid metabolism in hematologic malignancies and the era of targeted therapy', 'locator': '1014'}
{'index': 11, 'target_release_id': None, 'extra': {'authors': ['Warburg'], 'doi': '10.1126/science.123.3191.309', 'volume': '12'}, 'key': '12', 'year': 1956, 'container_name': 'Science', 'title': 'On the origin of cancer cells', 'locator': '309'}
{'index': 12, 'target_release_id': None, 'extra': {'authors': ['Stone'], 'doi': '10.1016/b978-0-12-416039-2.00015-x', 'volume': '50'}, 'key': '13', 'year': 2012, 'container_name': 'Methods Enzymol', 'title': 'Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer', 'locator': '291'}
{'index': 13, 'target_release_id': None, 'extra': {'authors': ['Huang'], 'doi': '10.1038/nm.4232', 'volume': '2'}, 'key': '14', 'year': 2017, 'container_name': 'Nat Med', 'title': 'Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth', 'locator': '120'}
{'index': 14, 'target_release_id': None, 'extra': {'authors': ['van Leeuwen'], 'doi': '10.1016/j.tem.2021.03.003', 'volume': '3'}, 'key': '15', 'year': 2021, 'container_name': 'Trends Endocrinol Metab', 'title': 'Amino Acid Depletion Therapies: Starving Cancer Cells to Death', 'locator': '367'}
{'index': 15, 'target_release_id': None, 'extra': {'authors': ['Cescon'], 'doi': '10.1016/j.ccell.2014.11.019', 'volume': '2'}, 'key': '16', 'year': 2015, 'container_name': 'Cancer Cell', 'title': 'Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression', 'locator': '211'}
{'index': 16, 'target_release_id': None, 'extra': {'authors': ['Huang'], 'doi': '10.1038/ncb2432', 'volume': '1'}, 'key': '17', 'year': 2012, 'container_name': 'Nat Cell Biol', 'title': 'Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia', 'locator': '276'}
{'index': 17, 'target_release_id': None, 'extra': {'authors': ['Gray'], 'doi': '10.1016/j.ccr.2013.08.020', 'volume': '2'}, 'key': '18', 'year': 2013, 'container_name': 'Cancer Cell', 'title': 'Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target', 'locator': '450'}
{'index': 18, 'target_release_id': None, 'extra': {'authors': ['Fanburg'], 'doi': '10.1152/ajplung.1989.257.4.l163', 'volume': '25'}, 'key': '19', 'year': 1989, 'container_name': 'Am J Physiol', 'title': 'Regulation of cellular glutathione', 'locator': 'L163'}
{'index': 19, 'target_release_id': None, 'extra': {'authors': ['Morales'], 'doi': '10.1152/ajpgi.1997.273.1.g7', 'volume': '27'}, 'key': '20', 'year': 1997, 'container_name': 'Am J Physiol', 'title': 'GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect', 'locator': 'G7'}
{'index': 20, 'target_release_id': None, 'extra': {'authors': ['Huang'], 'doi': '10.1038/nrd2803', 'volume': '8'}, 'key': '21', 'year': 2009, 'container_name': 'Nat Rev Drug Discov', 'title': 'Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?', 'locator': '579'}
{'index': 21, 'target_release_id': None, 'extra': {'authors': ['Srivastava'], 'doi': '10.1093/carcin/bgp157', 'volume': '3'}, 'key': '22', 'year': 2009, 'container_name': 'Carcinogenesis', 'title': 'Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells', 'locator': '1744'}
{'index': 22, 'target_release_id': None, 'extra': {'authors': ['Lee'], 'doi': '10.1038/nature10167', 'volume': '47'}, 'key': '23', 'year': 2011, 'container_name': 'Nature', 'title': 'Selective killing of cancer cells by a small molecule targeting the stress response to ROS', 'locator': '231'}
{'index': 23, 'target_release_id': None, 'extra': {'authors': ['Huang'], 'doi': '10.1016/j.ccr.2006.08.009', 'volume': '1'}, 'key': '24', 'year': 2006, 'container_name': 'Cancer Cell', 'title': 'Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate', 'locator': '241'}
{'index': 24, 'target_release_id': None, 'extra': {'authors': ['Choi'], 'doi': '10.3390/antiox8040082', 'volume': '8'}, 'key': '25', 'year': 2019, 'container_name': 'Antioxidants (Basel)', 'title': 'Protective Effect of Glutathione against Oxidative Stress-induced Cytotoxicity in RAW 264.7 Macrophages through Activating the Nuclear Factor Erythroid 2-Related Factor-2/Heme Oxygenase-1 Pathway', 'locator': '82'}
{'index': 25, 'target_release_id': None, 'extra': {'authors': ['Schumacker'], 'doi': '10.1016/j.ccr.2006.08.015', 'volume': '1'}, 'key': '26', 'year': 2006, 'container_name': 'Cancer Cell', 'title': 'Reactive oxygen species in cancer cells: live by the sword, die by the sword', 'locator': '175'}
{'index': 26, 'target_release_id': None, 'extra': {'authors': ['Aggarwal'], 'doi': '10.1208/s12248-009-9128-x', 'volume': '1'}, 'key': '27', 'year': 2009, 'container_name': 'AAPS J', 'title': 'Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?', 'locator': '495'}
{'index': 27, 'target_release_id': None, 'extra': {'authors': ['Fernández-Checa'], 'doi': '10.3389/fphar.2014.00151', 'volume': '5'}, 'key': '28', 'year': 2014, 'container_name': 'Front Pharmacol', 'title': 'Glutathione and mitochondria', 'locator': '151'}
{'index': 28, 'target_release_id': None, 'extra': {'authors': ['Bruchovsky'], 'doi': '10.1038/sj.leu.2402238', 'volume': '1'}, 'key': '29', 'year': 2001, 'container_name': 'Leukemia', 'title': 'Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug', 'locator': '1633'}
{'index': 29, 'target_release_id': None, 'extra': {'authors': ['Zhang'], 'doi': '10.1007/s13402-019-00474-8', 'volume': '4'}, 'key': '30', 'year': 2020, 'container_name': 'Cell Oncol (Dordr)', 'title': 'The Xinhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism', 'locator': '95'}
{'index': 30, 'target_release_id': None, 'extra': {'authors': ['Chandel'], 'doi': '10.1016/j.molcel.2012.09.025', 'volume': '4'}, 'key': '31', 'year': 2012, 'container_name': 'Mol Cell', 'title': 'Physiological roles of mitochondrial reactive oxygen species', 'locator': '158'}
{'index': 31, 'target_release_id': None, 'extra': {'authors': ['Spitz'], 'doi': '10.1016/j.freeradbiomed.2007.11.007', 'volume': '4'}, 'key': '32', 'year': 2008, 'container_name': 'Free Radic Biol Med', 'title': '2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress', 'locator': '826'}
{'index': 32, 'target_release_id': None, 'extra': {'authors': ['Kumar'], 'doi': '10.3390/antiox10050642', 'volume': '1'}, 'key': '33', 'year': 2021, 'container_name': 'Antioxidants (Basel)', 'title': 'Oxidative Stress in Cancer Cell Metabolism', 'locator': '642'}
{'index': 33, 'target_release_id': None, 'extra': {'authors': ['DiGiovanni'], 'doi': '10.1186/s13046-023-02677-2', 'volume': '4'}, 'key': '34', 'year': 2023, 'container_name': 'J Exp Clin Cancer Res', 'title': 'Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition', 'locator': '119'}
{'index': 34, 'target_release_id': None, 'extra': {'authors': ['Kirkpatrick'], 'doi': '10.1016/j.coph.2007.04.003', 'volume': '7'}, 'key': '35', 'year': 2007, 'container_name': 'Curr Opin Pharmacol', 'title': 'Thioredoxin signaling as a target for cancer therapy', 'locator': '392'}
{'index': 35, 'target_release_id': None, 'extra': {'authors': ['Holmgren'], 'doi': '10.1016/j.freeradbiomed.2013.07.036', 'volume': '6'}, 'key': '36', 'year': 2014, 'container_name': 'Free Radic Biol Med', 'title': 'The thioredoxin antioxidant system', 'locator': '75'}
{'index': 36, 'target_release_id': None, 'extra': {'authors': ['Rigobello'], 'doi': '10.1038/srep23071', 'volume': '6'}, 'key': '37', 'year': 2016, 'container_name': 'Sci Rep', 'title': 'Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State', 'locator': '23071'}
{'index': 37, 'target_release_id': None, 'extra': {'authors': ['Thomson'], 'doi': '10.1007/s40268-015-0083-y', 'volume': '1'}, 'key': '38', 'year': 2015, 'container_name': 'Drugs R D', 'title': 'Auranofin: repurposing an old drug for a golden new age', 'locator': '13'}
{'index': 38, 'target_release_id': None, 'extra': {'authors': ['Mak'], 'doi': '10.1038/nrc2981', 'volume': '1'}, 'key': '39', 'year': 2011, 'container_name': 'Nat Rev Cancer', 'title': 'Regulation of cancer cell metabolism', 'locator': '85'}
{'index': 39, 'target_release_id': None, 'extra': {'authors': ['Halliwell'], 'doi': '10.1042/bj3130017', 'volume': '31'}, 'key': '40', 'year': 1996, 'container_name': 'Biochem J', 'title': 'Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer', 'locator': '17'}
{'index': 40, 'target_release_id': None, 'extra': {'authors': ['DiGiovanni'], 'doi': '10.1038/s41698-019-0088-z', 'volume': '3'}, 'key': '41', 'year': 2019, 'container_name': 'NPJ Precis Oncol', 'title': 'Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth', 'locator': '16'}
{'index': 41, 'target_release_id': None, 'extra': {'authors': ['Nusse'], 'doi': '10.1038/35077199', 'volume': '41'}, 'key': '42', 'year': 2001, 'container_name': 'Making head or tail of Dickkopf. Nature', 'title': 'Developmental biology', 'locator': '255'}
{'index': 42, 'target_release_id': None, 'extra': {'authors': ['Hanada'], 'doi': '10.1007/s10565-018-9429-x', 'volume': '3'}, 'key': '43', 'year': 2018, 'container_name': 'Cell Biol Toxicol', 'title': 'Genome instability syndromes caused by impaired DNA repair and aberrant DNA damage responses', 'locator': '337'}
{'index': 43, 'target_release_id': None, 'extra': {'authors': ['Elledge'], 'doi': '10.1016/j.molcel.2010.09.019', 'volume': '4'}, 'key': '44', 'year': 2010, 'container_name': 'Mol Cell', 'title': 'The DNA damage response: making it safe to play with knives', 'locator': '179'}
{'index': 44, 'target_release_id': None, 'extra': {'authors': ['Krokan'], 'doi': '10.1016/j.mrfmmm.2003.06.002', 'volume': '53'}, 'key': '45', 'year': 2003, 'container_name': 'Mutat Res', 'title': 'The interacting pathways for prevention and repair of oxidative DNA damage', 'locator': '231'}
{'index': 45, 'target_release_id': None, 'extra': {'authors': ['Wilson'], 'doi': '10.1016/s0921-8777(98)00002-0', 'volume': '40'}, 'key': '46', 'year': 1998, 'container_name': 'Mutat Res', 'title': 'Mammalian base excision repair and DNA polymerase beta', 'locator': '203'}
{'index': 46, 'target_release_id': None, 'extra': {'authors': ['Nakamura'], 'doi': '10.18632/oncotarget.8298', 'volume': '7'}, 'key': '47', 'year': 2016, 'container_name': 'Oncotarget', 'title': 'Oxidative stress at low levels can induce clustered DNA lesions leading to NHEJ mediated mutations', 'locator': '25377'}
{'index': 47, 'target_release_id': None, 'extra': {'authors': ['Antonarakis'], 'doi': '10.2147/cmar.s227033', 'volume': '1'}, 'key': '48', 'year': 2020, 'container_name': 'Cancer Manag Res', 'title': 'PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date', 'locator': '8105'}
{'index': 48, 'target_release_id': None, 'extra': {'authors': ['Sboner'], 'doi': '10.1016/j.cell.2013.03.021', 'volume': '15'}, 'key': '49', 'year': 2013, 'container_name': 'Cell', 'title': 'Punctuated evolution of prostate cancer genomes', 'locator': '666'}
{'index': 49, 'target_release_id': None, 'extra': {'authors': ['Robinson'], 'doi': '10.1056/nejmoa1603144', 'volume': '37'}, 'key': '50', 'year': 2016, 'container_name': 'N Engl J Med', 'title': 'Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer', 'locator': '443'}
{'index': 50, 'target_release_id': None, 'extra': {'authors': ['Cancer Genome Atlas Research Network'], 'doi': '10.1016/j.cell.2015.10.025', 'volume': '16'}, 'key': '51', 'year': 2015, 'container_name': 'Cell', 'title': 'The Molecular Taxonomy of Primary Prostate Cancer', 'locator': '1011'}
{'index': 51, 'target_release_id': None, 'extra': {'authors': ['Bradley'], 'doi': '10.1016/j.cell.2015.05.001', 'volume': '16'}, 'key': '52', 'year': 2015, 'container_name': 'Cell', 'title': 'Integrative clinical genomics of advanced prostate cancer', 'locator': '1215'}
{'index': 52, 'target_release_id': None, 'extra': {'authors': ['Alimonti'], 'doi': '10.1038/s41568-020-0267-9', 'volume': '2'}, 'key': '53', 'year': 2020, 'container_name': 'Nat Rev Cancer', 'title': 'Prostate carcinogenesis: inflammatory storms', 'locator': '455'}
{'index': 53, 'target_release_id': None, 'extra': {'authors': ['Ng'], 'doi': '10.1200/jco.2016.69.1584', 'volume': '3'}, 'key': '54', 'year': 2017, 'container_name': 'J Clin Oncol', 'title': 'Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer', 'locator': '40'}
{'index': 54, 'target_release_id': None, 'extra': {'authors': ['Franke'], 'doi': '10.1016/s1470-2045(14)70189-5', 'volume': '1'}, 'key': '55', 'year': 2014, 'container_name': 'Lancet Oncol', 'title': 'Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial', 'locator': '700'}
{'index': 55, 'target_release_id': None, 'extra': {'authors': ['Beer'], 'doi': '10.18632/oncotarget.10547', 'volume': '7'}, 'key': '56', 'year': 2016, 'container_name': 'Oncotarget', 'title': 'Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer', 'locator': '52810'}
{'index': 56, 'target_release_id': None, 'extra': {'authors': ['Piha-Paul'], 'doi': '10.1093/annonc/mdy232', 'volume': '2'}, 'key': '57', 'year': 2018, 'container_name': 'Ann Oncol', 'title': 'Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study', 'locator': '1807'}
{'index': 57, 'target_release_id': None, 'extra': {'authors': ['Flohr'], 'doi': '10.1056/nejmoa1506859', 'volume': '37'}, 'key': '58', 'year': 2015, 'container_name': 'N Engl J Med', 'title': 'DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer', 'locator': '1697'}
{'index': 58, 'target_release_id': None, 'extra': {'authors': ['Yan'], 'doi': '10.1016/j.ccr.2011.04.010', 'volume': '1'}, 'key': '59', 'year': 2011, 'container_name': 'Cancer Cell', 'title': 'Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer', 'locator': '664'}
{'index': 59, 'target_release_id': None, 'extra': {'authors': ['Miranda'], 'doi': '10.1172/jci121924', 'volume': '12'}, 'key': '60', 'year': 2018, 'container_name': 'J Clin Invest', 'title': 'Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer', 'locator': '4441'}
{'index': 60, 'target_release_id': None, 'extra': {'authors': ['Li'], 'doi': '10.1038/s41586-019-1170-y', 'volume': '56'}, 'key': '61', 'year': 2019, 'container_name': 'Nature', 'title': 'CD8T cells regulate tumour ferroptosis during cancer immunotherapy', 'locator': '270'}
|